Skip to content

    Chambal Fert.

    CHAMBLFERTGood
    Chemicals·1 Aug 2025
    Management Summary

    Chambal Fertilisers delivered a strong Q1 FY26 performance characterized by significant volume growth in non-urea segments and steady progress on its capital projects. While urea production faced a temporary setback due to a plant breakdown, the P&K and Crop Protection (CPC-SN) segments showed robust momentum. Management is pivotally focused on the upcoming TAN plant commercialization and expanding its presence in seeds and biologicals to diversify revenue streams.

    Highlights

    7
    • Consolidated PAT grew 23% YoY to ₹549 crore, while Standalone PAT rose 16% to ₹638 crore.

    • P&K fertilizer sales volumes surged 70% YoY to 4.21 lakh metric tons, driven by strategic sourcing.

    • CPC-SN business revenue reached ₹452 crore, a 32% YoY growth, with a contribution of ₹102 crore.

    • Technical Ammonium Nitrate (TAN) project is on track with ₹918 crore spent; commercial production expected mid-January 2026.

    • Urea production was lower at 8.54 lakh MT (vs 9.03 lakh MT YoY) due to a 24-25 day breakdown at Gadepan-II.

    • Subsidy receipts remain timely with outstanding subsidy at ₹1,326 crore as of June 30, 2025.

    • Net cash on the balance sheet stood at approximately ₹1,600 crore as of quarter-end.

    Concerns

    1
    • Tightening of Energy Efficiency Norms

    Key financials

    Single quarter

    05 metrics
    1. 01Standalone Revenue₹5,698 Cr
    2. 02Standalone EBITDA₹929 Cr
    3. 03Consolidated PAT₹549 Cr+23%YoY
    4. 04P&K Sales Volume4.21 lakh MT+70%YoY
    5. 05CPC-SN Revenue₹452 Cr+32%YoY

    Segment breakdown

    Urea
    8.54 lakh MT Production Volume8.41 lakh MT Sales Volume
    P&K Fertilisers
    4.21 lakh MT Sales Volume
    CPC-SN
    ₹452 Cr Revenue₹102 Cr Contribution
    Seeds & Biologicals
    ₹6 Cr Seeds Revenue₹29 Cr Biologicals Revenue
    List

    Guidance & targets

    5
    CategoryTargetPriority
    Revenue
    CPC and SN Revenue
    ₹1,500 crore
    High
    Capacity
    TAN Commercial Production Start
    Mid-January 2026
    High
    Capacity
    IMACID Phosphoric Acid Capacity
    7 lakh tons
    Medium
    Capex
    Total TAN Project Capex
    ₹1,645 crore
    High
    Capex
    Normal Replacement Capex
    ₹250 crore
    Medium

    Risks & concerns

    5
    RiskSeverity

    Tightening of Energy Efficiency Norms

    Government reduction in energy norms creates a negative impact on margins, requiring continuous efficiency projects to maintain the gap.Both acknowledged

    high

    Plant Operational Reliability

    Gadepan-II breakdown resulted in a loss of ~55,000 tons of urea production and ₹16-17 crore in contribution.Management acknowledged

    medium

    TAN Market Supply Surplus

    Management expects a short-term supply surplus in the TAN market but remains optimistic about long-term demand from the coal mining sector.Management acknowledged

    medium

    Areas of Evasion(2)

    • Specific names of research partners for the seed and CPC business.
    • Internal estimations of the impact of post-2027 urea policy changes.

    Q&A highlights

    3

    “20 days on 92 days will be close to 20%... But even in terms of the turnover of the total Company... it is about of the order of 2% to 3%.”

    The analyst challenged management on why a 20-day shutdown (impacting 20% of urea volume) wasn't reported to exchanges; management argued it wasn't material to total company turnover.

    asked by Prashant Kumar Hazariwala

    2 min read5 chapters

    Detailed Narrative

    01

    P&K Segment Drives Non-Urea Growth

    The P&K fertilizer segment was a standout performer in Q1 FY26, with sales volumes growing 70% YoY to 4.21 lakh metric tons. This growth was supported by a strategic sourcing strategy and an enabling subsidy framework. Management noted that DAP and TSP volumes are trending back toward historical levels of over 1 million tons annually as government pricing approaches have moderated price shocks.

    02

    CPC-SN and New Business Verticals Gain Momentum

    The Crop Protection Chemicals and Specialty Nutrients (CPC-SN) business continued its strong trajectory with 32% revenue growth, reaching ₹452 crore. The company introduced 13 new products during the quarter, expanding its portfolio to 73 products. Additionally, Chambal entered the seed business (maize and bajra), contributing ₹6 crore to the top line, and saw an 80% sequential revenue jump in its biologicals segment to ₹29 crore.

    03

    TAN Project Execution and Financial Incentives

    The Technical Ammonium Nitrate (TAN) project is nearing completion with ₹918 crore of the ₹1,645 crore total capex already spent. Trial production is slated for late 2025, with full commercial operations starting in mid-January 2026. The project is eligible for Rajasthan state incentives (RIPS), which will provide a refund of approximately 2% of the ₹1,100 crore hard project cost annually for 10 years.

    04

    Urea Operations and Regulatory Headwinds

    Urea production was impacted by a breakdown at the Gadepan-II plant, leading to a 24-25 day shutdown in May and a production loss of ~55,000 tons. Furthermore, management acknowledged a reduction in government energy norms, which creates a 'low double-digit' crore impact per quarter. To counter this, the company has a pipeline of energy-efficiency projects stretching through FY27 to maintain its status as an efficient producer.

    05

    Strategic Joint Venture Expansion

    The company's joint venture, IMACID, is performing well and is currently undergoing a capacity expansion for Phosphoric Acid from 5 lakh to 7 lakh tons. This expansion, costing approximately $40-$45 million for the acid plant and $120-$130 million for a subsequent sulfuric acid plant, is expected to be operational by late 2026 or early 2027, further optimizing global sourcing for complex fertilizers.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.